+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Atenolol"

Atenolol Global Market Report 2024 - Product Thumbnail Image

Atenolol Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
From
Anti-Hypertensive Drugs Market Report 2025 - Product Thumbnail Image

Anti-Hypertensive Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Beta Blockers Market Report 2025 - Product Thumbnail Image

Beta Blockers Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Atenolol is a beta-blocker drug used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. It works by blocking the action of certain natural chemicals in the body, such as epinephrine, that affect the heart and blood vessels. Atenolol is usually taken once or twice daily, with or without food. It is available in tablet, capsule, and liquid form. Atenolol is a widely used drug in the cardiovascular market, as it is effective in treating a variety of conditions. It is also relatively inexpensive compared to other drugs in the same class. Additionally, it has a low risk of side effects, making it a popular choice for many patients. In the Atenolol market, some of the major players include Pfizer, Novartis, Merck, and GlaxoSmithKline. Other companies such as Mylan, Teva, and Sandoz also produce generic versions of the drug. Show Less Read more